NXTCL
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
NextCell Pharma is a Swedish clinical-stage cell therapy company developing treatments for immune-mediated diseases, with the company's most recent candidate being a type 1 diabetes candidate. The company's platform, NXTCL™, is designed to enable cell therapies with consistent efficacy, scalable manufacturing and the potential to change the course of the disease. NextCell is headquartered in Huddinge.
Læs mereOmsætning mio.
EBIT-% (adj.)
EPS (adj.)
Udbytte %
Delårsrapport Q3'26
Årsrapport '26
Delårsrapport Q1'27
Gå ikke glip af noget - opret en konto og få alle de mulige fordele
